List of Tables
Table 1. Global Blood Cancer Detection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Blood Cancer Detection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Blood Cancer Detection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Blood Cancer Detection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Blood Cancer Detection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Blood Cancer Detection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Blood Cancer Detection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Blood Cancer Detection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Blood Cancer Detection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Blood Cancer Detection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Blood Cancer Detection, Product Type & Application
Table 12. Global Key Manufacturers of Blood Cancer Detection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Blood Cancer Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Detection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Blood Cancer Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Blood Cancer Detection Sales by Region (2020-2025) & (K Units)
Table 18. Global Blood Cancer Detection Sales Market Share by Region (2020-2025)
Table 19. Global Blood Cancer Detection Sales by Region (2026-2031) & (K Units)
Table 20. Global Blood Cancer Detection Sales Market Share by Region (2026-2031)
Table 21. Global Blood Cancer Detection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Blood Cancer Detection Revenue Market Share by Region (2020-2025)
Table 23. Global Blood Cancer Detection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Blood Cancer Detection Revenue Market Share by Region (2026-2031)
Table 25. North America Blood Cancer Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Blood Cancer Detection Sales by Country (2020-2025) & (K Units)
Table 27. North America Blood Cancer Detection Sales by Country (2026-2031) & (K Units)
Table 28. North America Blood Cancer Detection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Blood Cancer Detection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Blood Cancer Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Blood Cancer Detection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Blood Cancer Detection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Blood Cancer Detection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Blood Cancer Detection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Blood Cancer Detection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Blood Cancer Detection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Blood Cancer Detection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Blood Cancer Detection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Blood Cancer Detection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Blood Cancer Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Blood Cancer Detection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Blood Cancer Detection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Blood Cancer Detection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Blood Cancer Detection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Blood Cancer Detection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Blood Cancer Detection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Blood Cancer Detection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Blood Cancer Detection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Blood Cancer Detection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Blood Cancer Detection Sales (K Units) by Type (2020-2025)
Table 51. Global Blood Cancer Detection Sales (K Units) by Type (2026-2031)
Table 52. Global Blood Cancer Detection Sales Market Share by Type (2020-2025)
Table 53. Global Blood Cancer Detection Sales Market Share by Type (2026-2031)
Table 54. Global Blood Cancer Detection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Blood Cancer Detection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Blood Cancer Detection Revenue Market Share by Type (2020-2025)
Table 57. Global Blood Cancer Detection Revenue Market Share by Type (2026-2031)
Table 58. Global Blood Cancer Detection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Blood Cancer Detection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Blood Cancer Detection Sales (K Units) by Application (2020-2025)
Table 61. Global Blood Cancer Detection Sales (K Units) by Application (2026-2031)
Table 62. Global Blood Cancer Detection Sales Market Share by Application (2020-2025)
Table 63. Global Blood Cancer Detection Sales Market Share by Application (2026-2031)
Table 64. Global Blood Cancer Detection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Blood Cancer Detection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Blood Cancer Detection Revenue Market Share by Application (2020-2025)
Table 67. Global Blood Cancer Detection Revenue Market Share by Application (2026-2031)
Table 68. Global Blood Cancer Detection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Blood Cancer Detection Price (US$/Unit) by Application (2026-2031)
Table 70. Abbott Laboratories Company Information
Table 71. Abbott Laboratories Description and Business Overview
Table 72. Abbott Laboratories Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Abbott Laboratories Blood Cancer Detection Product
Table 74. Abbott Laboratories Recent Developments/Updates
Table 75. F.Hoffman-LaRoche Company Information
Table 76. F.Hoffman-LaRoche Description and Business Overview
Table 77. F.Hoffman-LaRoche Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. F.Hoffman-LaRoche Blood Cancer Detection Product
Table 79. F.Hoffman-LaRoche Recent Developments/Updates
Table 80. QIAGEN Company Information
Table 81. QIAGEN Description and Business Overview
Table 82. QIAGEN Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. QIAGEN Blood Cancer Detection Product
Table 84. QIAGEN Recent Developments/Updates
Table 85. Thermo Fisher Scientific Company Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Thermo Fisher Scientific Blood Cancer Detection Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. lllumina Company Information
Table 91. lllumina Description and Business Overview
Table 92. lllumina Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. lllumina Blood Cancer Detection Product
Table 94. lllumina Recent Developments/Updates
Table 95. Bio-Rad Laboratories Company Information
Table 96. Bio-Rad Laboratories Description and Business Overview
Table 97. Bio-Rad Laboratories Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bio-Rad Laboratories Blood Cancer Detection Product
Table 99. Bio-Rad Laboratories Recent Developments/Updates
Table 100. MolecularMD Company Information
Table 101. MolecularMD Description and Business Overview
Table 102. MolecularMD Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. MolecularMD Blood Cancer Detection Product
Table 104. MolecularMD Recent Developments/Updates
Table 105. ArcherDX Company Information
Table 106. ArcherDX Description and Business Overview
Table 107. ArcherDX Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. ArcherDX Blood Cancer Detection Product
Table 109. ArcherDX Recent Developments/Updates
Table 110. ARUP Laboratories Company Information
Table 111. ARUP Laboratories Description and Business Overview
Table 112. ARUP Laboratories Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ARUP Laboratories Blood Cancer Detection Product
Table 114. ARUP Laboratories Recent Developments/Updates
Table 115. Asuragen Company Information
Table 116. Asuragen Description and Business Overview
Table 117. Asuragen Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Asuragen Blood Cancer Detection Product
Table 119. Asuragen Recent Developments/Updates
Table 120. Invivoscribe Company Information
Table 121. Invivoscribe Description and Business Overview
Table 122. Invivoscribe Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Invivoscribe Blood Cancer Detection Product
Table 124. Invivoscribe Recent Developments/Updates
Table 125. AdaptiveBiotechnologies Company Information
Table 126. AdaptiveBiotechnologies Description and Business Overview
Table 127. AdaptiveBiotechnologies Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. AdaptiveBiotechnologies Blood Cancer Detection Product
Table 129. AdaptiveBiotechnologies Recent Developments/Updates
Table 130. Amoy Diagnostics Company Information
Table 131. Amoy Diagnostics Description and Business Overview
Table 132. Amoy Diagnostics Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Amoy Diagnostics Blood Cancer Detection Product
Table 134. Amoy Diagnostics Recent Developments/Updates
Table 135. ELITechGroup Company Information
Table 136. ELITechGroup Description and Business Overview
Table 137. ELITechGroup Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. ELITechGroup Blood Cancer Detection Product
Table 139. ELITechGroup Recent Developments/Updates
Table 140. VelaDiagnostics Company Information
Table 141. VelaDiagnostics Description and Business Overview
Table 142. VelaDiagnostics Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. VelaDiagnostics Blood Cancer Detection Product
Table 144. VelaDiagnostics Recent Developments/Updates
Table 145. Gentronix Company Information
Table 146. Gentronix Description and Business Overview
Table 147. Gentronix Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Gentronix Blood Cancer Detection Product
Table 149. Gentronix Recent Developments/Updates
Table 150. BiolVT Company Information
Table 151. BiolVT Description and Business Overview
Table 152. BiolVT Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. BiolVT Blood Cancer Detection Product
Table 154. BiolVT Recent Developments/Updates
Table 155. SAGA Diagnostics Company Information
Table 156. SAGA Diagnostics Description and Business Overview
Table 157. SAGA Diagnostics Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. SAGA Diagnostics Blood Cancer Detection Product
Table 159. SAGA Diagnostics Recent Developments/Updates
Table 160. Olink Company Information
Table 161. Olink Description and Business Overview
Table 162. Olink Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Olink Blood Cancer Detection Product
Table 164. Olink Recent Developments/Updates
Table 165. Cancer Diagnostics Company Information
Table 166. Cancer Diagnostics Description and Business Overview
Table 167. Cancer Diagnostics Blood Cancer Detection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Cancer Diagnostics Blood Cancer Detection Product
Table 169. Cancer Diagnostics Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Blood Cancer Detection Distributors List
Table 173. Blood Cancer Detection Customers List
Table 174. Blood Cancer Detection Market Trends
Table 175. Blood Cancer Detection Market Drivers
Table 176. Blood Cancer Detection Market Challenges
Table 177. Blood Cancer Detection Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Blood Cancer Detection
Figure 2. Global Blood Cancer Detection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Blood Cancer Detection Market Share by Type: 2024 & 2031
Figure 4. Serve Product Picture
Figure 5. Detection Kit Product Picture
Figure 6. Global Blood Cancer Detection Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Blood Cancer Detection Market Share by Application: 2024 & 2031
Figure 8. Clinical Laboratory
Figure 9. Hospital
Figure 10. Academic Research Institution
Figure 11. Other
Figure 12. Global Blood Cancer Detection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Blood Cancer Detection Market Size (2020-2031) & (US$ Million)
Figure 14. Global Blood Cancer Detection Sales (2020-2031) & (K Units)
Figure 15. Global Blood Cancer Detection Average Price (US$/Unit) & (2020-2031)
Figure 16. Blood Cancer Detection Report Years Considered
Figure 17. Blood Cancer Detection Sales Share by Manufacturers in 2024
Figure 18. Global Blood Cancer Detection Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Blood Cancer Detection Players: Market Share by Revenue in Blood Cancer Detection in 2024
Figure 20. Blood Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Blood Cancer Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Blood Cancer Detection Sales Market Share by Country (2020-2031)
Figure 23. North America Blood Cancer Detection Revenue Market Share by Country (2020-2031)
Figure 24. United States Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Blood Cancer Detection Sales Market Share by Country (2020-2031)
Figure 27. Europe Blood Cancer Detection Revenue Market Share by Country (2020-2031)
Figure 28. Germany Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Blood Cancer Detection Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Blood Cancer Detection Revenue Market Share by Region (2020-2031)
Figure 35. China Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Blood Cancer Detection Sales Market Share by Country (2020-2031)
Figure 43. Latin America Blood Cancer Detection Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Blood Cancer Detection Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Blood Cancer Detection Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Blood Cancer Detection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Blood Cancer Detection by Type (2020-2031)
Figure 53. Global Revenue Market Share of Blood Cancer Detection by Type (2020-2031)
Figure 54. Global Blood Cancer Detection Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Blood Cancer Detection by Application (2020-2031)
Figure 56. Global Revenue Market Share of Blood Cancer Detection by Application (2020-2031)
Figure 57. Global Blood Cancer Detection Price (US$/Unit) by Application (2020-2031)
Figure 58. Blood Cancer Detection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
